Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection

Fig. 1

Tumor growth curve. The medulloblastoma tumor growth rate was decreased in the mice injected with splenocytes with IL-17. The mean tumor volume on day 28 in the splenocyte-injected group with IL-17 was smaller than in the splenocyte-injected group without IL-17 (1966.81 ± 378.16 mm3 in IL-17-treated group vs 4468.18 ± 923.64 mm3 in non-IL-17-treated group; P < 0.01). Meanwhile, the mean tumor volume in non-splenocyte-injected mice was the largest (6012.45 ± 572.95 mm3)

Back to article page